![Gaurav D. Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 5 M $ al 31/08/2026
Gaurav D.
Shah is currently Chief Executive Officer & Director at Rocket Pharmaceuticals, Inc. since 2018, President, Chief Executive Officer & Director at Rocket Pharmaceuticals Ltd. since 2015, and Chairman at Anjarium Biosciences AG since 2022.
Former roles include Medical Director at Eli Lilly & Co. from 2010 to 2011, Independent Director at Talaris Therapeutics, Inc., Head-Global Clinical Program at Novartis Corp.
from 2011 to 2015, and Assistant Professor-Oncology at The Trustees of Columbia University in The City of New York from 2009 to 2011.
Education includes a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Harvard College.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/08/2026 | 1.462.832 ( 1,33 % ) | 5 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Director Ejecutivo | 04/01/2018 |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Provides gene therapy services | Director Ejecutivo | 01/09/2015 |
Anjarium Biosciences AG
 Anjarium Biosciences AG BiotechnologyHealth Technology Develops non-viral gene therapy | Presidente | 18/10/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | 01/09/2015 |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2011 |
| ELI LILLY AND COMPANY | Director Técnico/Científico/I+D | 01/01/2011 |
| TOUE BIOPAR | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Provides gene therapy services | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Anjarium Biosciences AG
Anjarium Biosciences AG BiotechnologyHealth Technology Develops non-viral gene therapy | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
